查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
口蹄疫疫苗市場（類型：氫氧化鋁和皂素疫苗和油基疫苗；以及動物：牛、綿羊和山羊、豬/豬和其他） - 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1301471

口蹄疫疫苗市場（類型：氫氧化鋁和皂素疫苗和油基疫苗；以及動物：牛、綿羊和山羊、豬/豬和其他） - 2023-2031年全球行業分析、規模、佔有率、成長、趨勢和預測

Foot and Mouth Disease Vaccine Market (Type: Aluminum Hydroxide and Saponin Vaccines and Oil-based Vaccines; and Animal: Cattle, Sheep and Goat, Swine/Pig, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 158 Pages | 商品交期: 2-10個工作天內

價格

口蹄疫疫苗市場- 報告範圍

TMR關於全球口蹄疫疫苗市場的報告研究了過去以及當前的成長趨勢和機會，以獲得對2023年至2031年預測期間市場指標的寶貴見解。報告提供了2017-2031年期間全球口蹄疫疫苗市場的收入，考慮到2023年為基準年，2031年為預測年。報告還提供了2023年至2031年全球口蹄疫疫苗市場的複合年成長率（CAGR %）。

該報告是在廣泛的研究後編寫的。一級研究涉及大部分的研究工作，其中分析師與關鍵的意見領袖、行業領袖和意見製造者進行了訪談。二級研究包括參考主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解口蹄疫疫苗市場。

該報告深入研究了全球口蹄疫疫苗市場的競爭格局。在全球口蹄疫疫苗市場運作的主要參與者已被確定，其中每一個都在各種屬性方面進行了分析。公司概況、財務狀況、近期發展和SWOT是本報告對全球口蹄疫疫苗市場參與者的屬性描述。

目錄

第一章：前言

  • 市場定義和範圍
  • 市場細分
  • 主要研究目標
  • 研究重點

第二章：假設和研究方法

第三章：執行摘要：全球市場

第四章：市場概述

  • 簡介
    • 細分市場的定義
  • 概述
  • 市場動態
    • 驅動力
    • 限制因素
    • 機會
  • 2017-2031年全球市場分析和預測
    • 市場收入預測

第5章：關鍵洞察力

  • 口蹄疫概述
  • 疾病流行率和發病率概述
  • 監管情況
  • 主要行業事件
  • COVID-19大流行對行業的影響（價值鍊和短/中/長期影響）。

第六章：全球市場分析與預測：按類型分類

  • 介紹和定義
  • 主要研究結果/發展
  • 市場價值預測：按類型，2017-2031年
    • 氫氧化鋁和皂素類疫苗
    • 油基疫苗
      • 單油乳劑
      • 雙油乳劑
  • 市場吸引力：按類型分類

第七章：全球市場分析和預測：按動物分類

  • 介紹和定義
  • 主要研究結果/發展
  • 市場價值預測：按動物分類，2017-2031年
    • 牛
    • 綿羊和山羊
    • 豬
    • 其他動物
  • 市場吸引力：按動物分類

第八章：全球市場分析與預測：按配銷通路分類

  • 介紹和定義
  • 主要發現/發展
  • 市場價值預測：按配銷通路，2017-2031年
    • 獸醫診所
    • 政府機構
    • 其他管道
  • 市場吸引力：按配銷通路分類

第九章：全球市場分析和預測：按地區分類

  • 主要研究結果
  • 市場價值預測：按地區
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
    • 世界其他地區
  • 市場吸引力：按國家/地區

第十章：亞太地區市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按類型，2017-2031年
    • 氫氧化鋁和皂素類疫苗
    • 油基疫苗
      • 單油乳劑
      • 雙油乳劑
  • 市場價值預測：按動物分類，2017-2031年
    • 牛
    • 綿羊和山羊
    • 豬
    • 其他動物
  • 市場價值預測：按配銷通路，2017-2031年
    • 獸醫診所
    • 政府機構
    • 其他
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 中國
    • 印度
    • 亞太其他地區
  • 市場吸引力分析
    • 按類型
    • 按動物分類
    • 按銷售管道分類
    • 按國家/次區域分類

第11章：拉丁美洲市場分析與預測

  • 簡介
    • 主要發現
  • 市場價值預測：按類型，2017-2031年
    • 氫氧化鋁和皂素類疫苗
    • 油基疫苗
      • 單油乳劑
      • 雙油乳劑
  • 市場價值預測：按動物分類，2017-2031年
    • 牛
    • 綿羊和山羊
    • 豬
    • 其他動物
  • 市場價值預測：按配銷通路，2017-2031年
    • 獸醫診所
    • 政府機構
    • 其他
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地區
  • 市場吸引力分析
    • 按類型
    • 按動物分類
    • 按銷售管道分類
    • 按國家/次區域分類

第十二章：中東和非洲市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按類型，2017-2031年
    • 氫氧化鋁和皂素類疫苗
    • 油基疫苗
      • 單油乳劑
      • 雙油乳劑
  • 市場價值預測：按動物分類，2017-2031年
    • 牛
    • 綿羊和山羊
    • 豬
    • 其他動物
  • 市場價值預測：按配銷通路，2017-2031年
    • 獸醫診所
    • 政府機構
    • 其他
  • 市場價值預測：按國家/次區域分類，2017-2031年
    • 海灣合作理事會國家
    • 南非
    • 中東和非洲其他地區
  • 市場吸引力分析
    • 按類型
    • 按動物分類
    • 按銷售管道分類
    • 按國家/次區域分類

第13章：世界其他地區的市場分析和預測

  • 簡介
    • 主要發現
  • 市場價值預測：按類型，2017-2031年
    • 氫氧化鋁和皂素類疫苗
    • 油基疫苗
      • 單油乳劑
      • 雙油乳劑
  • 市場價值預測：按動物分類，2017-2031年
    • 牛
    • 綿羊和山羊
    • 豬
    • 其他動物
  • 市場價值預測：按配銷通路，2017-2031年
    • 獸醫診所
    • 政府機構
    • 其他管道
  • 市場吸引力分析
    • 按類型
    • 按動物分類
    • 按銷售管道分類

第十四章：競爭格局

  • 市場參與者- 競爭矩陣（按公司的層級和規模）。
  • 公司簡介
    • BVI
    • Indian Immunologicals Ltd.
    • Ceva Sante Animale
    • MEVAC
    • National Veterinary Institute
    • Limor de Colombia SAS
    • Brilliant Bio Pharma
    • Biogenesis Bago
    • Kenya Veterinary Vaccines Production Institute
    • Boehringer Ingelheim International GmbH
    • Zoetis, Inc.
    • Ourofino Saude Animal
Product Code: TMRGL2480

Foot and Mouth Disease Vaccine Market - Scope of Report

TMR's report on the global Foot and Mouth Disease Vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Foot and Mouth Disease Vaccine market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Foot and Mouth Disease Vaccine market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Foot and Mouth Disease Vaccine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Foot and Mouth Disease Vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Foot and Mouth Disease Vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Foot and Mouth Disease Vaccine market.

The report delves into the competitive landscape of the global Foot and Mouth Disease Vaccine market. Key players operating in the global Foot and Mouth Disease Vaccine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Foot and Mouth Disease Vaccine market profiled in this report.

Key Questions Answered in Global Foot and Mouth Disease Vaccine Market Report:

  • What is the sales/revenue generated by Foot and Mouth Disease Vaccine across all regions during the forecast period?
  • What are the opportunities in the global Foot and Mouth Disease Vaccine market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Foot and Mouth Disease Vaccine Market - Research Objectives and Research Approach

The comprehensive report on the global Foot and Mouth Disease Vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Foot and Mouth Disease Vaccine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Foot and Mouth Disease Vaccine market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Foot and Mouth Disease Vaccine Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Foot and Mouth Disease Overview
  • 5.2. Disease Prevalence & Incidence Rate Overview
  • 5.3. Regulatory Scenario
  • 5.4. Key Industry Events
  • 5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

6. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Aluminum Hydroxide and Saponin Vaccines
    • 6.3.2. Oil-based Vaccines
      • 6.3.2.1. Single-oil Emulsion
      • 6.3.2.2. Double-oil Emulsion
  • 6.4. Market Attractiveness, by Type

7. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Animal

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Animal, 2017-2031
    • 7.3.1. Cattle
    • 7.3.2. Sheep and Goat
    • 7.3.3. Swine/Pig
    • 7.3.4. Others
  • 7.4. Market Attractiveness, by Animal

8. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Veterinary Clinics
    • 8.3.2. Government Institutions
    • 8.3.3. Others
  • 8.4. Market Attractiveness, by Distribution Channel

9. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. Asia Pacific
    • 9.2.2. Latin America
    • 9.2.3. Middle East & Africa
    • 9.2.4. Rest of the World
  • 9.3. Market Attractiveness, by Country/Region

10. Asia Pacific Foot and Mouth Disease Vaccine Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Aluminum Hydroxide and Saponin Vaccines
    • 10.2.2. Oil-based Vaccines
      • 10.2.2.1. Single-oil Emulsion
      • 10.2.2.2. Double-oil Emulsion
  • 10.3. Market Value Forecast, by Animal, 2017-2031
    • 10.3.1. Cattle
    • 10.3.2. Sheep and Goat
    • 10.3.3. Swine/Pig
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Veterinary Clinics
    • 10.4.2. Government Institutions
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.5.1. China
    • 10.5.2. India
    • 10.5.3. Rest of Asia Pacific
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Animal
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country/Sub-region

11. Latin America Foot and Mouth Disease Vaccine Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Aluminum Hydroxide and Saponin Vaccines
    • 11.2.2. Oil-based Vaccines
      • 11.2.2.1. Single-oil Emulsion
      • 11.2.2.2. Double-oil Emulsion
  • 11.3. Market Value Forecast, by Animal, 2017-2031
    • 11.3.1. Cattle
    • 11.3.2. Sheep and Goat
    • 11.3.3. Swine/Pig
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Veterinary Clinics
    • 11.4.2. Government Institutions
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Brazil
    • 11.5.2. Argentina
    • 11.5.3. Rest of Latin America
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Animal
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Middle East & Africa Foot and Mouth Disease Vaccine Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Aluminum Hydroxide and Saponin Vaccines
    • 12.2.2. Oil-based Vaccines
      • 12.2.2.1. Single-oil Emulsion
      • 12.2.2.2. Double-oil Emulsion
  • 12.3. Market Value Forecast, by Animal, 2017-2031
    • 12.3.1. Cattle
    • 12.3.2. Sheep and Goat
    • 12.3.3. Swine/Pig
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Veterinary Clinics
    • 12.4.2. Government Institutions
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. GCC Countries
    • 12.5.2. South Africa
    • 12.5.3. Rest of Middle East & Africa
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Animal
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Rest of the World Foot and Mouth Disease Vaccine Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Aluminum Hydroxide and Saponin Vaccines
    • 13.2.2. Oil-based Vaccines
      • 13.2.2.1. Single-oil Emulsion
      • 13.2.2.2. Double-oil Emulsion
  • 13.3. Market Value Forecast, by Animal, 2017-2031
    • 13.3.1. Cattle
    • 13.3.2. Sheep and Goat
    • 13.3.3. Swine/Pig
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Veterinary Clinics
    • 13.4.2. Government Institutions
    • 13.4.3. Others
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Type
    • 13.5.2. By Animal
    • 13.5.3. By Distribution Channel

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Company Profiles
    • 14.2.1. BVI
      • 14.2.1.1. Company Overview
      • 14.2.1.2. Financial Overview
      • 14.2.1.3. Product Portfolio
      • 14.2.1.4. Business Strategies
      • 14.2.1.5. Recent Developments
    • 14.2.2. Indian Immunologicals Ltd.
      • 14.2.2.1. Company Overview
      • 14.2.2.2. Financial Overview
      • 14.2.2.3. Product Portfolio
      • 14.2.2.4. Business Strategies
      • 14.2.2.5. Recent Developments
    • 14.2.3. Ceva Sante Animale
      • 14.2.3.1. Company Overview
      • 14.2.3.2. Financial Overview
      • 14.2.3.3. Product Portfolio
      • 14.2.3.4. Business Strategies
      • 14.2.3.5. Recent Developments
    • 14.2.4. MEVAC
      • 14.2.4.1. Company Overview
      • 14.2.4.2. Financial Overview
      • 14.2.4.3. Product Portfolio
      • 14.2.4.4. Business Strategies
      • 14.2.4.5. Recent Developments
    • 14.2.5. National Veterinary Institute
      • 14.2.5.1. Company Overview
      • 14.2.5.2. Financial Overview
      • 14.2.5.3. Product Portfolio
      • 14.2.5.4. Business Strategies
      • 14.2.5.5. Recent Developments
    • 14.2.6. Limor de Colombia SAS
      • 14.2.6.1. Company Overview
      • 14.2.6.2. Financial Overview
      • 14.2.6.3. Product Portfolio
      • 14.2.6.4. Business Strategies
      • 14.2.6.5. Recent Developments
    • 14.2.7. Brilliant Bio Pharma
      • 14.2.7.1. Company Overview
      • 14.2.7.2. Financial Overview
      • 14.2.7.3. Product Portfolio
      • 14.2.7.4. Business Strategies
      • 14.2.7.5. Recent Developments
    • 14.2.8. VETAL Animal Health Products, Inc.
      • 14.2.8.1. Company Overview
      • 14.2.8.2. Financial Overview
      • 14.2.8.3. Product Portfolio
      • 14.2.8.4. Business Strategies
      • 14.2.8.5. Recent Developments
    • 14.2.9. Biogenesis Bago
      • 14.2.9.1. Company Overview
      • 14.2.9.2. Financial Overview
      • 14.2.9.3. Product Portfolio
      • 14.2.9.4. Business Strategies
      • 14.2.9.5. Recent Developments
    • 14.2.10. Kenya Veterinary Vaccines Production Institute
      • 14.2.10.1. Company Overview
      • 14.2.10.2. Financial Overview
      • 14.2.10.3. Product Portfolio
      • 14.2.10.4. Business Strategies
      • 14.2.10.5. Recent Developments
    • 14.2.11. Boehringer Ingelheim International GmbH
      • 14.2.11.1. Company Overview
      • 14.2.11.2. Financial Overview
      • 14.2.11.3. Product Portfolio
      • 14.2.11.4. Business Strategies
      • 14.2.11.5. Recent Developments
    • 14.2.12. Zoetis, Inc.
      • 14.2.12.1. Company Overview
      • 14.2.12.2. Financial Overview
      • 14.2.12.3. Product Portfolio
      • 14.2.12.4. Business Strategies
      • 14.2.12.5. Recent Developments
    • 14.2.13. Ourofino Saude Animal
      • 14.2.13.1. Company Overview
      • 14.2.13.2. Financial Overview
      • 14.2.13.3. Product Portfolio
      • 14.2.13.4. Business Strategies
      • 14.2.13.5. Recent Developments

List of Tables

  • Table 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 02: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 03: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 04: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 05: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Region, 2017-2031
  • Table 06: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 07: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 08: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 09: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 10: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 12: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 13: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 14: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 15: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 17: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 18: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 19: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031
  • Table 22: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031
  • Table 23: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031
  • Table 24: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 02: Foot and Mouth Disease Vaccine Market Value Share, by Type, 2022
  • Figure 03: Foot and Mouth Disease Vaccine Market Value Share, by Animal, 2022
  • Figure 04: Foot and Mouth Disease Vaccine Market Value Share, by Distribution Channel, 2022
  • Figure 05: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 06: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 07: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Aluminum Hydroxide and Saponin Vaccines, 2017-2031
  • Figure 08: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Oil-based Vaccines, 2017-2031
  • Figure 09: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 10: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 11: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Cattle, 2017-2031
  • Figure 12: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Sheep and Goat, 2017-2031
  • Figure 13: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Swine/Pig, 2017-2031
  • Figure 14: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031
  • Figure 15: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 16: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 17: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Veterinary Clinics, 2017-2031
  • Figure 18: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Government Institutions, 2017-2031
  • Figure 19: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031
  • Figure 20: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 21: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 23: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 24: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 25: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 26: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 27: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 28: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 29: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 31: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 32: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 33: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 34: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 35: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 36: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 37: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 38: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 40: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 41: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 42: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 43: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 44: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 45: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 46: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 47: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 49: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031
  • Figure 50: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031
  • Figure 51: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 52: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031
  • Figure 53: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031
  • Figure 54: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 55: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031